European Heart Journal Advance Access originally published online on November 18, 2005
European Heart Journal 2006 27(2):130-131; doi:10.1093/eurheartj/ehi625
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The European Society of Cardiology 2005. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
Effectiveness of catheter ablation of atrial fibrillation
Harvard-Thorndike Electrophysiology Institute, Cardiovascular Division, Beth Israel Deaconess Medical Center, 185 Pilgrim Road, Baker 4, Boston, MA 02215, USA
* Corresponding author. Tel: +1 617 632 7393; fax: +1 617 632 7620. E-mail address: mjoseph2@bidmc.harvard.edu
This editorial refers to Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized controlled study (Catheter Ablation for the Cure of Atrial Fibrillation Study)
by G. Stabile et al., on page 216
| The first 10% of the full text of this article appears below. |
Catheter ablation of atrial fibrillation (AF) has become increasingly popular in multiple centres worldwide as more studies have reported favourable success rates in preventing AF recurrences using various ablation techniques.1 Different strategies for ablating AF range from physiological approaches aimed at electrical segmental pulmonary vein (PV) isolation2,3 to anatomical circumferential PV ablation with or without the addition of linear ablation lines in the posterior left atrium and in the mitral isthmus.4,5 Recent randomized studies comparing these approaches have yielded conflicting results concerning the relative merits of segmental PV isolation vs. circumferential PV ablation.5,6 Despite numerous studies reporting results of different ablation techniques
Acknowledgement
![]()
CiteULike
Connotea
Del.icio.us What's this?
Related articles in EHJ:
- Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study)
- Giuseppe Stabile, Emanuele Bertaglia, Gaetano Senatore, Antonio De Simone, Franco Zoppo, Giovanni Donnici, Pietro Turco, Pietro Pascotto, Massimo Fazzari, and Dino Franco Vitale
EHJ 2006 27: 216-221.[Abstract] [FREE Full Text]
This article has been cited by other articles:
![]() |
D. C. Peters, J. V. Wylie, T. H. Hauser, R. Nezafat, Y. Han, J. J. Woo, J. Taclas, K. V. Kissinger, B. Goddu, M. E. Josephson, et al. Recurrence of atrial fibrillation correlates with the extent of post-procedural late gadolinium enhancement a pilot study. J. Am. Coll. Cardiol. Img., March 1, 2009; 2(3): 308 - 316. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Peters, J. V. Wylie, T. H. Hauser, K. V. Kissinger, R. M. Botnar, V. Essebag, M. E. Josephson, and W. J. Manning Detection of Pulmonary Vein and Left Atrial Scar after Catheter Ablation with Three-dimensional Navigator-gated Delayed Enhancement MR Imaging: Initial Experience Radiology, March 1, 2007; 243(3): 690 - 695. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Willems, H. Klemm, T. Rostock, B. Brandstrup, R. Ventura, D. Steven, T. Risius, B. Lutomsky, and T. Meinertz Substrate modification combined with pulmonary vein isolation improves outcome of catheter ablation in patients with persistent atrial fibrillation: a prospective randomized comparison Eur. Heart J., December 1, 2006; 27(23): 2871 - 2878. [Abstract] [Full Text] [PDF] |
||||


